StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Dilution

<< Previous

Bullboard Posts

Next >>

Comment by brad129on Nov 16, 2021 4:18pm

143 Views

Post# 34133623

RE:RE:RE:RE:RE:RE:Dilution

Mykndrsn wrote: I'd rather be down than down and out. Anybody invested here with the patience they lack and the doubts they've expressed has to be an idiot with no one to blame but themselves. The company in its current form is about a month old. Think I'll stick around a while and make money. I can afford to wait.

"The company in its current form is about a month old. Think I'll stick around a while and make money. I can afford to wait. "

exact same things were said back in 2016 after they had the big trouble. It's a whole new company and now we own our Lab.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China